How about Jiangsu Yunyang Group Pharmaceutical Co., Ltd.?

Brief introduction: Jiangsu Yunyang Group Pharmaceutical Co., Ltd. has workshops for synthesis, tablets, eye drops, nasal drops, tincture liniments and Chinese patent medicines, with nearly 90 product varieties. Clotrimazole was developed in 1984, with an annual production capacity of 100 tons, accounting for more than 60% of the domestic market, and exported to Southeast Asian and Eastern European countries. The domestic market share of clonidine hydrochloride (raw materials and tablets) is over 90%. Zhenju Jiangya Tablet, a Chinese patent medicine, is favored by users because of its obvious antihypertensive effect, no toxic side effects and popular price, and its sales volume has doubled year by year. In recent years, our company has continuously intensified product innovation, and the national new drugs Yumei Tablet (a new cough medicine) and Meloxicam (a raw material medicine and tablet for treating rheumatism) have been officially listed. Zijin Gantai Capsule and Yishen Shengxue Tablet were clinically approved. In order to speed up the development of new drugs, the company is strengthening cooperation with universities and research institutes to seize the commanding heights of new drug development.

Legal Representative: Ma Jun..

Date of establishment: July 2003-65438+July.

Registered capital: 1.00 million yuan.

Location: Jiangsu Province

Unified social credit code: 91321181752709469x.

Operating conditions: In operation.

Industry: manufacturing industry

Company type: limited liability company

English name: Jiangsu Yunyang Group Pharmaceutical Co., Ltd.

Staff size: 100-500 people.

Enterprise address: Shunkang Road 18, Danyang Economic Development Zone, Jiangsu Province

Business scope: manufacture of tablets, hard capsules (including anti-tumor), nasal drops, eye drops, tinctures, liniments, syrups, liquid ointments, oral liquids, raw materials (clotrimazole, propafenone hydrochloride, clonidine hydrochloride, propranolol hydrochloride, clozapine, meloxicam, atorvastatin calcium, miconazole nitrate and econazole nitrate), and pretreatment and extraction of traditional Chinese medicines. (Projects subject to approval according to law can only be operated after approval by relevant departments)